Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)

NACompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

October 24, 2013

Primary Completion Date

November 21, 2018

Study Completion Date

October 20, 2020

Conditions
Cervical Cancer
Interventions
PROCEDURE

Tumor biopsies

Tumor biopsies will be performed before and after treatment.

PROCEDURE

Blood sampling

Blood sampling will be performed before and after treatment.

Trial Locations (24)

21079

Centre Georges Francois Leclerc, Dijon

21204

Clinic for operative oncology, Institute of oncology of Vojvodina, Kamenitz

30625

Mhh Hanover - Hanover Medical School, Hanover

34298

Institut Régional du Cancer de Montpellier - Val D'Aurelle, Montpellier

49933

Institut de Cancérologie de l'Ouest - Paul Papin, Angers

54519

Institut de Cancérologie de Lorraine- ICL NANCY, Vandœuvre-lès-Nancy

67065

Centre Paul Strauss, Strasbourg

75015

Hopital Europeen Georges Pompidou, Paris

75248

Insitut Curie, Paris

75877

Groupe Hospitalier Bichat, Paris

94010

Centre Hospitalier Intercommunal de Créteil - CHI Créteil, Créteil

94805

Institut de Cancerologie Gustave Roussy, Villejuif

300041

Clinica de radioterapie, Timișoara

410469

"Spitalul Clinic Municipal Gavril Curteanu", Oradea

500091

Teo Health S.A. - Spitalul Sf. Constantin, Brasov

Unknown

Institut Bergonié, Bordeaux

Centre Léon Bérard, Lyon

Institut de Cancérologie de Lorraine - ICL, Nancy

Institut de Cancérologie de l'Ouest - RENE GAUDUCHEAU, Nantes

Hôpital Tenon, Paris

Institut René Huguenin, Saint-Cloud

06189

Centre Antoine Lacassagne, Nice

91105 AZ

Amsterdam Medical Center (AMC), Amsterdam

1006 BE

Netherland Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam

All Listed Sponsors
lead

Institut Curie

OTHER

NCT02428842 - Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4) | Biotech Hunter | Biotech Hunter